[Federal Register Volume 68, Number 246 (Tuesday, December 23, 2003)]
[Notices]
[Page 74275]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 03-31546]


=======================================================================
-----------------------------------------------------------------------

SECURITIES AND EXCHANGE COMMISSION


Issuer Delisting; Notice of Application To Withdraw From Listing 
and Registration on the American Stock Exchange LLC (Vasogen Inc., 
Common Stock, No Par Value) File No. 0-29350

December 17, 2003.
    Vasogen Inc., a Canada corporation (``Issuer''), has filed an 
application with the Securities and Exchange Commission 
(``Commission''), pursuant to section 12(d) of the Securities Exchange 
Act of 1934 (``Act'')\1\ and Rule 12d2-2(d) thereunder,\2\ to withdraw 
its common stock, no par value (``Security''), from listing and 
registration on the American Stock Exchange LLC (``Amex'' or 
``Exchange'').
---------------------------------------------------------------------------

    \1\ 15 U.S.C. 78l(d).
    \2\ 17 CFR 240.12d2-2(d).
---------------------------------------------------------------------------

    The Board of Directors (``Board'') of the Issuer approved a 
resolution on December 9, 2003 to withdraw the Issuer's Security from 
listing on the Amex and to list such Security on the Nasdaq National 
Market System (``Nasdaq NMS''). The Board states that it considered the 
following reason in its decision to withdraw the Security from listing 
and registration on the Amex: listing on the Nasdaq NMS represents a 
logical next step to support of the Issuer's growth while offering 
shareholders increased liquidity.
    The Issuer stated in its application that it has met the 
requirements of Amex Rule 18 by complying with all applicable laws in 
Canada, in which it is incorporated, and with the Amex's rules 
governing an issuer's voluntary withdrawal of a security from listing 
and registration.
    The Issuer's application relates solely to the withdrawal of the 
Securities from listing on the Amex and from registration under section 
12(b) of the Act \3\ and shall not affect its obligation to be 
registered under section 12(g) of the Act.\4\
---------------------------------------------------------------------------

    \3\ 15 U.S.C. 78l(b).
    \4\ 15 U.S.C. 78l(g).
---------------------------------------------------------------------------

    Any interested person may, on or before January 9, 2004, submit by 
letter to the Secretary of the Securities and Exchange Commission, 450 
Fifth Street, NW., Washington, DC 20549-0609, facts bearing upon 
whether the application has been made in accordance with the rules of 
the Amex and what terms, if any, should be imposed by the Commission 
for the protection of investors. The Commission, based on the 
information submitted to it, will issue an order granting the 
application after the date mentioned above, unless the Commission 
determines to order a hearing on the matter.

    For the Commission, by the Division of Market Regulation, 
pursuant to delegated authority.\5\
---------------------------------------------------------------------------

    \5\ 17 CFR 200.30-3(a)(1).
---------------------------------------------------------------------------

Jonathan G. Katz,
Secretary.
[FR Doc. 03-31546 Filed 12-22-03; 8:45 am]
BILLING CODE 8010-01-P